These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

192 related items for PubMed ID: 1980930

  • 1. Alpha-blocker therapy; a possible advance in the treatment of diabetic hypertension--results of a cross-over study of doxazosin and atenolol monotherapy in hypertensive non-insulin dependent diabetic subjects.
    Feher MD, Henderson AD, Wadsworth J, Poulter C, Gelding S, Richmond W, Sever PS, Elkeles RS.
    J Hum Hypertens; 1990 Oct; 4(5):571-7. PubMed ID: 1980930
    [Abstract] [Full Text] [Related]

  • 2. Clinical efficacy and tolerability of alpha-blocker doxazosin as add-on therapy in patients with hypertension and impaired glucose metabolism.
    Pessina AC, Ciccariello L, Perrone F, Stoico V, Gussoni G, Scotti A, Muggeo M.
    Nutr Metab Cardiovasc Dis; 2006 Mar; 16(2):137-47. PubMed ID: 16487914
    [Abstract] [Full Text] [Related]

  • 3. Long-term effects of doxazosin and atenolol on serum lipids and blood pressure in hypertensive smokers.
    Talseth T, Westlie L, Daae LN.
    J Hypertens Suppl; 1990 Sep; 8(5):S47-51. PubMed ID: 1981077
    [Abstract] [Full Text] [Related]

  • 4. Acute lipoprotein changes associated with atenolol therapy for hypertension in non-insulin dependent diabetes.
    Feher MD, Torrens DJ, Richmond W, Wadsworth J, Sever PS, Elkeles RS.
    J Hum Hypertens; 1988 Dec; 2(4):253-5. PubMed ID: 3236327
    [Abstract] [Full Text] [Related]

  • 5. A long-term study of atenolol and doxazosin in mild and moderate hypertension.
    Talseth T, Westlie L, Daae L.
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():39-44. PubMed ID: 2148194
    [Abstract] [Full Text] [Related]

  • 6. [The effects of bisoprolol and atenolol on glucose metabolism in hypertensive patients with non-insulin-dependent diabetes mellitus].
    Vulpis V, Antonacci A, Prandi P, Bokor D, Pirrelli A.
    Minerva Med; 1991 Apr; 82(4):189-93. PubMed ID: 1673233
    [Abstract] [Full Text] [Related]

  • 7. Antihypertensive drugs and the hypertensive diabetic patient.
    Feher M.
    J Hum Hypertens; 1990 Oct; 4 Suppl 3():7-9. PubMed ID: 1979821
    [Abstract] [Full Text] [Related]

  • 8. Effects of selective alfa 1 and beta 1-adrenoreceptor blockade on lipoprotein and carbohydrate metabolism in hypertensive subjects, with special emphasis on insulin sensitivity.
    Andersson PE, Johansson J, Berne C, Lithell H.
    J Hum Hypertens; 1994 Mar; 8(3):219-26. PubMed ID: 8006923
    [Abstract] [Full Text] [Related]

  • 9. Antihypertensive effect of doxazosin and atenolol in short- and long-term double-blind comparison.
    Lijnen P, Fagard R, Staessen J, Amery A.
    Methods Find Exp Clin Pharmacol; 1990 Oct; 12(8):563-73. PubMed ID: 2151197
    [Abstract] [Full Text] [Related]

  • 10. Effects of a 3-month treatment with terazosin on fasting and postprandial glucose and lipid metabolism in type 2 diabetic patients with hypertension.
    Pasanisi F, Imperatore G, Vaccaro O, Iovine C, Ferrara LA.
    Nutr Metab Cardiovasc Dis; 1999 Apr; 9(2):73-7. PubMed ID: 10726112
    [Abstract] [Full Text] [Related]

  • 11. Selective alpha 1 inhibition with doxazosin in hypertensive smokers and non-smokers: haemodynamic and metabolic effects.
    Westheim A, Daae LN, Kierulf P, Brusletto B, Holme I, Syvertsen JO.
    J Hypertens Suppl; 1990 Sep; 8(5):S41-6. PubMed ID: 1981076
    [Abstract] [Full Text] [Related]

  • 12. Serum lipid changes in a one-year, multicenter, double-blind comparison of doxazosin and atenolol for mild to moderate essential hypertension.
    Frick MH, Cox DA, Himanen P, Huttunen M, Pitkäjärvi T, Pörsti P, Pöyhönen L, Pyykönen ML, Reinikainen P, Salmela P.
    Am J Cardiol; 1987 May 29; 59(14):61G-67G. PubMed ID: 2884854
    [Abstract] [Full Text] [Related]

  • 13. [Efficacy of and tolerance to prolonged release prazosin in patients with hypertension and non-insulin dependent diabetes].
    Hanon O, Giacomino A, Troy S, Bernaud C, Girerd X, Weber S.
    Ann Cardiol Angeiol (Paris); 2000 Oct 29; 49(7):390-6. PubMed ID: 12555491
    [Abstract] [Full Text] [Related]

  • 14. Combined effect of doxazosin and pindolol on blood pressure control and lipid concentrations in patients with essential hypertension selected from general practice. Hunter Hypertension Research Group.
    J Hum Hypertens; 1992 Jun 29; 6(3):181-4. PubMed ID: 1352827
    [Abstract] [Full Text] [Related]

  • 15. Metabolic and cardiovascular effects of carvedilol and atenolol in non-insulin-dependent diabetes mellitus and hypertension. A randomized, controlled trial.
    Giugliano D, Acampora R, Marfella R, De Rosa N, Ziccardi P, Ragone R, De Angelis L, D'Onofrio F.
    Ann Intern Med; 1997 Jun 15; 126(12):955-9. PubMed ID: 9182472
    [Abstract] [Full Text] [Related]

  • 16. Meta-analysis of studies using selective alpha1-blockers in patients with hypertension and type 2 diabetes.
    Glanz M, Garber AJ, Mancia G, Levenstein M.
    Int J Clin Pract; 2001 Dec 15; 55(10):694-701. PubMed ID: 11777296
    [Abstract] [Full Text] [Related]

  • 17. Effects of doxazosin on ambulatory blood pressure and sympathetic nervous activity in hypertensive Type 2 diabetic patients with overt nephropathy.
    Yasuda G, Hasegawa K, Kuji T, Ogawa N, Shimura G, Umemura S, Tochikubo O.
    Diabet Med; 2005 Oct 15; 22(10):1394-400. PubMed ID: 16176202
    [Abstract] [Full Text] [Related]

  • 18. Insulin sensitivity following treatment with the alpha 1-blocker bunazosin retard and the beta 1-blocker atenolol in hypertensive non-insulin-dependent diabetes mellitus patients.
    Eriksson JW, Jansson PA, Foley K, Lithell H.
    J Hypertens; 1996 Dec 15; 14(12):1469-75. PubMed ID: 8986932
    [Abstract] [Full Text] [Related]

  • 19. [Antihypertensive therapy with doxazosin in patients with non-insulin-dependent diabetes mellitus].
    Lazebnik LB, Melichenko SB, Serebrov AN.
    Ter Arkh; 1998 Dec 15; 70(2):50-4. PubMed ID: 9551574
    [Abstract] [Full Text] [Related]

  • 20. Efficacy and tolerability of slow release urapidil (ebrantil) in hypertensive patients with non-insulin dependent diabetes mellitus (NIDDM).
    Oren S, Turkot S, Paran E, Flandra O, Slezak L, Hof B.
    J Hum Hypertens; 1996 Feb 15; 10(2):123-7. PubMed ID: 8867567
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 10.